Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
05/1999
05/25/1999US5906993 Anticancer, antitumor agent
05/25/1999US5906990 Taxoids, preparation thereof, and pharmaceutical compositions containing same
05/25/1999US5906938 Method of reconstituting hematopoietic cells using monoclonal antibodies to the stem cell factor receptor
05/25/1999CA2070497C Novel platinum (ii) complex and antitumor agent
05/20/1999WO1999024836A1 125 human secreted proteins
05/20/1999WO1999024603A1 Method for identifying drug targets
05/20/1999WO1999024583A1 Dna demethylase, therapeutic and diagnostic uses thereof
05/20/1999WO1999024566A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis
05/20/1999WO1999024559A2 Nuclear targeting by means of streptococcal protein h
05/20/1999WO1999024474A1 Detoxication of active pharmaceutical substances using cyclodextrine oligomers
05/20/1999WO1999024469A1 Secreted proteins and polynucleotides encoding them
05/20/1999WO1999024460A2 Dipeptide nitriles
05/20/1999WO1999024440A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
05/20/1999WO1999024430A1 Novel camptothecin derivatives
05/20/1999WO1999024416A1 Aminothiazole inhibitors of cyclin dependent kinases
05/20/1999WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999WO1999024404A1 Substituted pyridine compounds as anti-inflammatory agents
05/20/1999WO1999024401A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999WO1999024073A1 Pharmaceutical compositions containing cyclodextrins and taxoids
05/20/1999WO1999024060A1 Interferon immunotherapy
05/20/1999WO1999024052A2 Use of protein h as cytostatic agent
05/20/1999WO1999024048A1 Cancer treatment drug
05/20/1999WO1999024045A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999WO1999024029A1 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
05/20/1999WO1999015665A3 Mutants of thyroid stimulating hormone and methods based thereon
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
05/20/1999WO1999009182A3 Rab proteins
05/20/1999WO1999007736A3 Lipoprotein-regulating medicaments
05/20/1999WO1999001118A9 Antioxidant enhancement of therapy for hyperproliferative conditions
05/20/1999WO1998031796A8 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
05/20/1999DE19750529A1 New heterocyclic alpha-hydroxycarboxylic acid derivatives useful for treating hypertension, chronic coronary insufficiency, asthma, prostate cancer etc.
05/20/1999CA2309690A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents
05/20/1999CA2309652A1 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
05/20/1999CA2309640A1 Nuclear targeting by means of bacterial proteins
05/20/1999CA2309557A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis
05/20/1999CA2309321A1 Use of alkylated iminosugars to treat multidrug resistance
05/20/1999CA2309206A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells
05/20/1999CA2309007A1 Secreted proteins and polynucleotides encoding them
05/20/1999CA2308768A1 125 human secreted proteins
05/20/1999CA2308582A1 Method for identifying drug targets
05/20/1999CA2308373A1 Interferon immunotherapy
05/20/1999CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
05/20/1999CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity
05/20/1999CA2276276A1 Cancer treatment drug
05/19/1999EP0916737A2 Polynucleotide compounds for hybridizing to target polynucleotides
05/19/1999EP0916671A1 Metalloprotease inhibitors, process for their preparation and pharmaceutical compositions containing them
05/19/1999EP0916666A1 3-alkyloxy-,aryloxy-, or arylalkyloxy-benzo[b]thiophene-2-carboxamides as inhibitors of cell adhesion
05/19/1999EP0916663A1 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3,13(16), 14-clerodatrien-2-one (Esculentin A) and 18Beta, 19Beta-diacetyloxy-18Alpha, 19Alpha-epoxy-3, 12, 14-clerodatrien-2Beta-isovaleryloxy-6Beta, 7Alpha-diol (Esculentin B), a process for their preparation, and their use in the manufacture of medicaments
05/19/1999EP0916336A1 Transdermal delivery system
05/19/1999EP0915974A1 Modified tie-2-receptor ligands
05/19/1999EP0915908A1 Dolastatin pentapeptide derivatives and their use as antitumor agents
05/19/1999EP0915904A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor
05/19/1999EP0915895A1 New salts of anionic complexes of ru(iii), as antimetastatic and antineoplastic agents
05/19/1999EP0915872A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
05/19/1999EP0915871A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
05/19/1999EP0915870A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation
05/19/1999EP0915869A1 Novel tricyclic n-cyanoimines useful as inhibitors of farnesyl-protein transferase
05/19/1999EP0915850A1 Novel carbocyclic diarylmethylene derivatives, methods for preparing same, and therapeutical uses thereof
05/19/1999EP0915848A1 1,2-diarylindole as cox-2 inhibitors
05/19/1999EP0915845A1 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
05/19/1999EP0915823A1 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
05/19/1999EP0915819A1 Illudin analogs useful as antitumor agents
05/19/1999EP0915708A1 Cancer immunotherapy using autologous tumor cells combined with allogeneic cytokine-secreting cells
05/19/1999EP0915703A1 Combinations of an ursodeoxycholic acid compound and a nsaid for the chemopreventive protection of the colorectum
05/19/1999EP0915700A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
05/19/1999EP0915698A1 Therapeutic treatment for vegf related diseases
05/19/1999EP0752986B1 N-heterocyclyl sulphonamide derivatives and their use as endothelin antagonists
05/19/1999EP0666857B1 Method for preparing taxane derivatives
05/19/1999EP0552257B1 A plant protein useful for treating tumors and hiv infection
05/19/1999CN1217024A Chemokine alpha 2
05/19/1999CN1216978A New vitamin-D derivatives with carbo- or heterocyclic substitutents at C-25, process for the prodn. intermediate products and their use for producing medicaments
05/19/1999CN1216921A Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
05/19/1999CN1216767A Novel 5-membered ring heterocycles, their prepn. their use and pharmaceutical preparations comprising them
05/19/1999CN1216685A Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
05/19/1999CN1043405C Method for prepn. of pharmaceutical compositions contg. heterocyclic amide derivatives
05/18/1999US5905149 Substituted quinolymethylen-oxindole analogues as tyrosine kinase inhibitors
05/18/1999US5905076 Treatment of muscular dystrophy, arthritis, myocardial infarction, alzheimer's disease, bacterial infection, common cold, osteoporosis or cancer metastasis
05/18/1999US5905074 Skin disorders, antitumor agents, vitamin d derivatives
05/18/1999US5904930 Hydroxytamoxifen derivatives in solutions
05/18/1999US5904920 Regulation of systemic immune responses utilizing cytokines and antigens
05/14/1999WO1999023230A1 Reagents and methods useful for detecting diseases of the breast
05/14/1999WO1999023220A1 Suppressor of cytokine signaling
05/14/1999WO1999023216A2 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
05/14/1999WO1999023112A1 A FUSION PROTEIN OF hEGF AND HUMAN ANGIOGENIN, AND PROCESS FOR PREPARING THE SAME
05/14/1999WO1999023108A1 Inducible phosphofructokinase and the warburg effect
05/14/1999WO1999023106A1 Caspase-14 polypeptides
05/14/1999WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth
05/14/1999WO1999023104A2 Antitumour uridine analogues
05/14/1999WO1999023096A1 Phthalocyanine analogs
05/14/1999WO1999023078A2 Novel carboxylic acid derivatives which carry amide side chains, production of said carboxylic acid derivatives and their use as endothelin receptor antagonists
05/14/1999WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999WO1999022775A1 Methods for treating prostate tumors using radioactive compositions
05/14/1999WO1999022774A1 Radioactive embolizing compositions
05/14/1999WO1999022764A1 Methods and compositions comprising glycoprotein glycoforms
05/14/1999WO1999022760A1 Method and compositions for inhibiting angiogenesis and treating cancer
05/14/1999WO1999022749A1 Galenic preparation for prevention and treatment of hepatocarcinoma
05/14/1999WO1999022741A1 Antimutagenic compositions for treatment and prevention of photodamage to skin
05/14/1999WO1999022729A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
1 ... 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 1978 1979 1980 1981 1982 1983 1984 1985 1986 ... 2211